European Respiratory Journal Open Research Papers

The European Respiratory Journal, the official journal of the European Respiratory Society, publishes 12 issues in two volumes per year in English.

The ERJ publishes clinical and experimental work relating to all aspects of respiratory medicine, including cell biology, epidemiology, immunology, pathophysiology, thoracic imaging, paediatric pneumology, occupational medicine, intensive care, sleep medicine, thoracic surgery and thoracic oncology. In addition to such original material, the ERJ prints editorials, reviews, series articles, correspondence and letters to the editor.

The ERJ takes part in the HINARI Programme. The HINARI Programme, set up by the World Health Organization together with major publishers, enables developing countries to gain access to collections of biomedical and health literature. Over 6400 journal titles are now available to health institutions in 108 countries, areas and territories, benefiting many thousands of health workers and researchers, in turn contributing to improved world health. For more information about HINARI, go to www.who.int/hinari/en/

All submissions to the ERJ are handled via the ScholarOne Manuscripts platform, which provides detailed instructions of how to follow the submission process. If you experience problems or require any further assistance, please contact the submission helpline direct on +44 114 2672864 or contact Gill Archer, ScholarOne Manuscripts coordinator.

Manuscript preparation

Presentation of manuscripts should be consistent with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, as recommended by the International Committee of Medical Journal Editors (ICMJE).

All manuscripts must be submitted electronically using the online submission at ScholarOne Manuscripts. Detailed instructions of how to submit are available on the website itself and the process is self explanatory. However, if you do experience problems, please contact the submission helpline direct on +44 114 2672864 or contact Gill Archer, ScholarOne Manuscripts coordinator.

European Respiratory Journal manuscripts should be prepared in accordance with the manuscript preparation guidelines for ERS research publications. These cover manuscript content as well as ethical, authorship and conflict of interest considerations.

Before entering the ERJ ScholarOne online submission area, please read and carefully follow the manuscript preparation guidelines and the information below.

Brief requirements for articles are summarised in the following table. Further details can be found in the manuscript preparation guidelines.

Article typeWord limitFigures and tablesReferencesOnline supplementAbstract
Original research3000840AcceptedYes, 200 words
Editorials1500230Not acceptedNo
Review and series articles50005200AcceptedYes, 200 words
Research letters1200115Not acceptedNo
Correspondence800110Not acceptedNo
Task force reports, guidelines and consensus statements800015250AcceptedYes, 200 words
ERJ Methods1500130Not acceptedNo

The number of figures and tables in the above summary refers to the total number of both; for example, letters can have either one figure or one table, not one of each.

Peer review

On submission of your manuscript, you will be notified by e-mail on receipt of the submitted online draft and provided with a manuscript number for future reference.

Each manuscript will be reviewed by the chief editor and associate editors. Because the European Respiratory Journal receives many times more submissions that it can publish, manuscripts that are not regarded as sufficiently original or high in priority may be rejected after review by the editors. We will aim to communicate such a decision to you quickly so you can consider other publication routes for your work.

Manuscripts not rejected at this stage will be subjected to peer review by external reviewers and statistical advisors. After your manuscript has been reviewed, you may be requested to make changes to your manuscript arising from reviewer comments. When submitting your revised manuscript, two copies must be provided: one clean copy of the revised manuscript, and one copy in which all of the text added as a result of reviewer comments is highlighted in red.

The reviewers and associate editors will recommend their decisions to the chief editor, who will then be responsible for the final decision to accept or reject a manuscript.

If your manuscript is rejected after peer review, and you wish to appeal the decision, please e-mail a letter of rebuttal to: ERJEditors@ersj.org.uk

In the appeal letter, you should clearly state your name, the title of your manuscript and the manuscript number. Furthermore, it will help us to handle your appeal if you can provide specific point-by-point responses to any comments made by the editors and reviewers in support of their original decision. We will respond to all appeals as soon as possible, but of course in some cases it may take some time to make a final decision. The decision of the chief editor is final and only one appeal will be considered per manuscript.

What we expect from submissions to the ERJ

The following information should allow authors to evaluate whether their work is likely to be of interest to the ERJ.

Randomised controlled trials

We encourage the submission of high quality randomised controlled trials. In accordance with ICMJE guidance, ERJ will only publish randomised controlled trials that were prospectively registered in a WHO compliant clinical trial registry. Prospectively registered is defined as the trial information being available publicly prior to the first patient being enrolled. Trials must be reported according to CONSORT guidelines. A data sharing statement should be included with all clinical trial submissions indicating whether the authors wish to make primary data available to other research groups.

We encourage authors to consider submitting manuscripts focused on the protocol of major randomised controlled trials and observational studies to our sister journal, ERJ Open Research.

Observational and cohort studies

Epidemiological studies should be conducted and reported according to STROBE guidelines. Registration on a WHO compliant registry is encouraged for prospective observational studies but is not mandatory.

Priority will be given to observational research with novel findings that have been replicated in independent cohorts. Specific study types will usually require replication, e.g. genetic association studies and prognostic or diagnostic scoring systems. In general, the ERJ will not publish new diagnostic or prognostic scoring systems without evidence of independent validation.

Systematic reviews and meta-analyses

Systematic reviews and meta-analyses should be registered on the PROSPERO database.

Systematic reviews and meta-analyses will only be considered for publication if they provide additional information to the literature beyond information available from the source studies. Reporting should follow PRISMA guidelines. Meta-analysis of observational data should follow MOOSE guidelines.

Biomarker studies

As above for observational studies, novel biomarker associations will usually require independent validation. Where biomarkers have been correlated with multiple clinical outcomes, or multiple biomarkers measured in a single study, adjustment for multiple statistical testing is mandatory.

Basic and translational science

The ERJ is committed to publishing excellent studies into the mechanism of disease which may include studies without direct or immediate clinical relevance. For studies that do not involve patient samples or experimental models of disease (e.g. in vitro mechanistic studies only) the authors should make clear in the cover letter to the editor why the manuscript is suited to the ERJ rather than more specialised mechanistic science journals. Please note that in vitro studies using only a single immortalised or tumour cell line are unlikely to be considered for publication in the ERJ.

Review and series articles

High quality reviews should seek to inform and educate reviewers and should stimulate debate around clinical and scientific topics. The literature review should be up to date. Systematic review methods are encouraged but are not mandatory. Note that systematic reviews that include quantitative data analysis, i.e. meta-analysis, should be submitted as original research.

Review articles in the ERJ are typically highly read and highly cited. As such, they should represent the state of the art in their specific field. The ERJ welcomes unsolicited review articles but also commissions reviews across the breadth of respiratory medicine. As such, only the highest quality articles will be accepted. Submitted papers should not overlap substantially with any recently published reviews on similar topics. The use of imaginative figures is strongly encouraged.

When submitting an unsolicited review, the authors are recommended to explain in the cover letter why they consider themselves especially suited to write the review, and include references to a maximum of five of their own recent and relevant publications supporting their specific expertise in the area of the review.

The current review series are:

  • State of the Art
    Concise reviews on the latest in pulmonary and critical care medicine and translational science from leading experts
  • Back to Basics
    Accessible reviews aiming to discuss the cutting edge of respiratory basic science in a way that is suitable for clinicians and researchers in other fields

ERJ Methods

A new feature for 2018 is ERJ Methods, a series of concise articles designed to introduce readers to novel, complex or highly specialised methodologies, technologies or techniques in respiratory medicine. Examples include clinical, imaging, biomarker or statistical techniques. The objective of these articles should be to educate non-experts and allow them to better interpret research being published in the ERJ and elsewhere.

Authors of ERJ Methods articles are asked to answer three simple questions:

  • How does it work?
  • What is the current state of the art in respiratory medicine using this technology/method?
  • How is it likely to be used in future?

Articles should be no more than 1500 words and a single summary figure is strongly encouraged. Unsolicited manuscripts are welcome.

Fast-track publication

For exceptional articles, reports of large randomised controlled trials or areas of major scientific or public health interest we will aim to fast-track manuscripts with review within 72 hours and first decision within 1 week of submission. If you believe your article requires fast-track review please mention this in the cover letter of your manuscript along with a detailed justification of why the article should be fast-tracked. Please note that the final decision will be made by the chief editors/section editors.

Copyright

Submission of the manuscript implies that if and when it is accepted for publication, the authors automatically agree to transfer the copyright to the publisher wherever possible. The copyright transfer implies that the publisher holds the exclusive right to reproduction in any form (including publication in another language) and distribution of any of the articles in the journal. Material published in the European Respiratory Journal may not be stored in any electronic format, or be reproduced photographically, except with the prior written permission of the publisher.

In the event that the paper is accepted for publication, all authors will be contacted and asked to complete an online form transferring copyright to ERS. All authors must complete this online form before the paper can be published.

Further to the transfer of publishing rights to the ERS, authors can opt to make their article open access through the ERJ Open scheme, and are permitted to self-archive their manuscripts after the journal’s embargo period has elapsed.

Full details regarding open access, public archiving and funder mandates can be found in the following section.

More information regarding copyright transfer can be found at erj.ersjournals.com/authors/copyright

Open Access

What is ERJ Open?

ERJ Open is an optional service offered by the European Respiratory Society that enables authors to ensure that their final published contribution is made available for anyone to access online, immediately on publication. This option is an important part of our response to the changing expectations of authors, readers and funding bodies who support research and scholarly communication. ERJ Open is compliant with the publisher requirements for open access publication set out by Wellcome.

Costs

Standard option. The standard ERJ Open service costs €2000. Articles will be published under a Creative Commons Attribution Non-commercial (CC BY-NC) 4.0 copyright licence (creativecommons.org).

Mandated option. A number of funding bodies now mandate that open access articles be published under a Creative Commons Attribution (CC BY) 4.0 copyright licence (creativecommons.org). ERS makes this service available to authors whose funding body requires it, at a cost of €3000. To qualify, the funder must be among those listed at erj.ersjournals.com/authors/cc-by-funders

Payment in EUR is preferred, although other currencies may be permissible subject to contacting our accounts department. The article charge does not cover any other costs associated with publication, e.g. charges for colour printing, about which you would have been be notified when your article was accepted for publication. You will be required to complete and submit an article charge form. Authors may pay the article charge themselves or provide billing details of funders who have agreed to pay on their behalf. If the person or organisation paying the fee is based in the European Union, VAT may be payable. Pre-payment in full is required to activate ERJ Open. If the ERS does not receive payment of the fee, the article will not be published open access.

The article charge form for ERJ Open articles can be downloaded here. If you wish to pay via credit card, the additional credit card payment form can be found here.

What happens to an open access paper?

You should submit your paper according to the journal’s instructions for authors and guidance on preparation of manuscripts. Only after your paper is accepted for publication will you be able to request that your paper is published open access; your choice to pay for this open access service will not affect the peer-review process, and payment of an open access fee will not secure preferential treatment.

ERJ Open is available immediately upon online publication (i.e. in ERJ In Press if your article meets the criteria for inclusion in the In Press section) through to final publication (in a print and online monthly issue). All ERJ Open articles will be identified by means of an icon in the table of contents and search results.

In addition, ERJ Open articles will carry the following notice:

©ERS 20XX. ERJ Open articles are open access and distributed under the terms of the Creative Commons Attribution [Non-commercial] Licence 4.0.

The ERS as the publisher will deposit the full text of your article in PubMed Central (PMC) upon final publication.

At this time, the ERS does not allow articles that have already been published to be made open access.

Terms and conditions for ERJ Open papers

It is ERS policy to require copyright assignment for all European Respiratory Journal articles to enable efficient handling of rights, to safeguard authors against plagiarism and infringement and to protect and authenticate the final published version. For more details, please refer to our copyright form.

ERJ Open articles are protected by copyright. Publishing an ERJ Open paper enables legitimate distribution of your work online under the terms of the relevant Creative Commons licence.

ERJ Open articles published with the standard CC BY-NC licence have no restriction on their use, distribution and reproduction in any medium provided it is for non-commercial purposes, and that the original work is properly cited. If a paper is not reproduced in its entirety but only in part, or as a derivative work, this must be clearly stated.

Use of ERJ Open articles published with a standard CC BY-NC licence for commercial, promotional or marketing purposes requires further explicit permission from ERS (permissions@ersj.org.uk) and may be subject to a fee. Commercial purposes include:

  • copying or downloading articles, for further redistribution, sale or licensing;
  • copying, downloading or posting by a site or service that incorporates advertising with such content;
  • the inclusion or incorporation of article content in other works or services that are then available for sale or licensing, for a fee;
  • use of article content by for-profit organisations for promotional purposes;
  • use for the purposes of monetary reward by means of sale, resale, licence, loan, transfer or other form of commercial exploitation such as marketing products.

ERJ Open articles published with the mandated CC BY licence have no restriction on their use, distribution and reproduction in any medium provided that the original work is properly cited.

Print reprints and eprints of ERJ Open articles can be purchased from permissions@ersj.org.uk

Refund policy

If you decide to publish your article with one of our open access licences and pay the article processing charge outlined above, you will be eligible for a refund if:
1. We publish your article with an incorrect licence, and we fail to correct and republish the article within 1 month of you having informed us of the error; 
2. We fail to deposit your article to PMC within 2 months of final publication of the article on our own website; or
3. We fail to publish an author correction or erratum concerning your article within 2 months of you having informed us of the error, subject to our agreement that the reported correction necessitates correction and republication of the article, per our usual policies.

“Green” open access and author archiving

Authors who do not wish to pay for the ERJ Open option will still have their manuscripts made free to access via the ERJ online archive following the journal’s 18-month embargo period; after this embargo period, authors also have licence to deposit their manuscripts in an institutional (or similar) repository for public archiving, provided the following requirements are met:

1) The final, peer-reviewed, author-submitted version that was accepted for publication is used (before copy-editing and publication).

2) A permanent link is provided to the version of the article published in the ERJ, through the dx.doi.org platform. For example, if your manuscript has the DOI 10.1183/09031936.00123412, then the link you provide must be https://doi.org/10.1183/09031936.00123412

3) The repository on which the manuscript is deposited is not used for systematic distribution or commercial sales purposes.

4) The following required archiving statement appears on the title page of the archived manuscript: “This is an author-submitted, peer-reviewed version of a manuscript that has been accepted for publication in the European Respiratory Journal, prior to copy-editing, formatting and typesetting. This version of the manuscript may not be duplicated or reproduced without prior permission from the copyright owner, the European Respiratory Society. The publisher is not responsible or liable for any errors or omissions in this version of the manuscript or in any version derived from it by any other parties. The final, copy-edited, published article, which is the version of record, is available without a subscription 18 months after the date of issue publication.”

Manuscripts funded by NIH or Europe PubMed Central Funders Group members

The European Respiratory Journal now has in place an author-pays open access scheme, ERJ Open (see above). For authors of manuscripts funded by the National Institutes of Health (NIH) or Europe PubMed Central Funders Group members who do not wish to take up this option, the following allowances apply, in addition to the author archiving policy outlined above.

For manuscripts with NIH or Europe PMC funding, the journal acknowledges that the author retains the right to provide a copy of the final, peer-reviewed author-supplied manuscript (before copy-editing and publication) for public archiving in PubMed Central in compliance with the requirements of the funder, i.e. 12 months after the final publication date for authors with funding from the NIH, and 6 months after final publication for authors with funding from Europe PubMed Central Funders Group members.

Other funder mandates

If your research body mandates an access or archiving model that is not addressed above, please contact info@ersj.org.uk

In memoria

The European Respiratory Society supports the announcement of In memoria through the ERS website and ERS Newsletter, which provide the widest audience for respiratory community and society news. Please contact the ERS Communications team to discuss the posting of an announcement (press@europeanlung.org).

The ERJ will publish In memoria only in exceptional cases. Please contact the chief editor to discuss suitability prior to writing an announcement, including information on whether there are plans to disseminate the announcement in other journals or society newsletters.

CME

Accepted manuscripts deemed to be of educational value are submitted to EBAP (the European Board for Accreditation in Pneumology) for accreditation as Continuing Medical Education (CME) articles. European Respiratory Journal readers then have the chance to earn CME credits by reading such articles and correctly answering a selection of multiple choice questions about the manuscript in question.

If your article is deemed to be of educational value, upon acceptance for publication, you may be asked to provide four to six multiple-choice questions to be published with the article. Prompt composition of such questions will enable the timely publication of the article and the ERJ.

From January 1, 2010, CME credits will be free of charge. For more information, visit the CME page.

After your paper is accepted: getting the most out of your publication

After your manuscript is accepted for publication in the European Respiratory Journal, it will be passed to the ERS publications office for copyediting and typesetting. A member of the publications office staff will contact you regarding copyright assignment; original research articles, research letters, review articles and task force reports will be eligible for publication immediately after copyright transfer is complete as "Early View" articles in their accepted form. After our initial production processes are complete, we will send a proof of the article to the corresponding author, along with any queries that have arisen during our production processes. When the proofs have been checked and approved, the article will be published in its final form in the next available issue of the ERJ

Once published online, selected papers will be promoted by the ERS communications department, through press releases, ERS marketing channels or social media. If your own institution is carrying out press activity around your paper, please let us know. The ERS has also created an authors’ guide to using social media to gain exposure and feedback.

If you have further ideas and would like help promoting your work, please contact the editorial office: info@ersj.org.uk

For the Chinese version click here

For the Spanish version click here

European Respiratory Journal instructions for authors, June 2017.

This page was updated on December 20, 2017

ERJ Open Research publishes clinical and experimental work relating to all aspects of respiratory basic science, clinical translational science and clinical medicine, including cell biology, epidemiology, immunology, pathophysiology, thoracic imaging, paediatric pneumology, occupational medicine, intensive care, sleep medicine, thoracic surgery and thoracic oncology. In addition to such original material, editorials, reviews, series articles, letters to the editor and correspondence will be considered for publication.

All submissions to ERJ Open Research are handled via the ScholarOne Manuscripts platform, which provides detailed instructions of how to follow the submission process. If you experience problems or require and further assistance, please contact the submission helpline direct on +44 114 2672868 or contact info@ersj.org.uk.

Manuscript preparation

Presentation of manuscripts should be consistent with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, as recommended by the International Committee of Medical Journal Editors (ICMJE).

All manuscripts must be submitted electronically using the online submission at ScholarOne Manuscripts. Detailed instructions of how to submit are available on the website itself and the process is self explanatory. However, if you do experience problems, please contact the submission helpline direct on +44 114 2672868 or contact Caroline.Ashford-Bentley@ersj.org.uk, ScholarOne Manuscripts coordinator.

Before entering the ERJ Open Research ScholarOne online submission area, please read and carefully follow the manuscript preparation guidelines and the information below.

Article typeWord limitFigures and tablesReferencesOnline supplementAbstract
Original research3000840AcceptedYes, 200 words
Editorials1500230Not acceptedNo
Review articles50005200AcceptedYes, 200 words
Research letters1200115Not acceptedNo
Correspondence800110Not acceptedNo

The number of figures and tables in the above summary refers to the total number of both; for example, letters can have either one figure or one table, not one of each.

Peer review

When you have completed your submission, you will be notified by e-mail and provided with a manuscript number for future reference.

Each manuscript will be reviewed by the chief editor and an associate editor. Manuscripts that are not regarded as sufficiently original, high in priority or otherwise suitable for publication in ERJ Open Research may be rejected after review by the editors. We will aim to communicate such a decision to you quickly so you can consider other publication routes for your work.

Manuscripts not rejected at this stage will be subject to peer review by external reviewers. After your manuscript has been reviewed, you may be asked to revise it in line with reviewer comments. When submitting your revised manuscript, you should provide two copies: one clean copy of the revised manuscript, and one copy in which the changes from the original version are clearly highlighted.

The reviewers and associate editor will recommend their decisions to the chief editor, who will then be responsible for the final decision to accept or reject a manuscript.

If your manuscript is rejected after peer review, and you wish to appeal the decision, please e-mail a letter of rebuttal to: info@ersj.org.uk

In the appeal letter, you should clearly state your name, the title of your manuscript and the manuscript number. It will help us to handle your appeal if you can provide specific point-by-point responses to any comments made by the editors and reviewers in support of their original decision. We will respond to all appeals as soon as possible, but in some cases it may take some time to make a final decision. The decision of the chief editor is final and only one appeal will be considered per manuscript.

ERJ Open Research uses iThenticate plagiarism detection software. Manuscripts showing a high degree of similarity to previously published work will be closely examined and any appropriate action will be taken by the Chief Editor.

Copyright, open access and author archiving

Copyright transfer

Submission of the manuscript implies that if and when it is accepted for publication, the authors agree to transfer the copyright to the publisher. The publisher will then make the article available under the relevant open access licence.

In the event that the paper is accepted for publication, all authors will be contacted and asked to complete an online form transferring copyright to ERS. All authors must complete this online form before the paper can be published.

Exceptions to copyright transfer

The European Respiratory Society recognises that there may be cases where an author’s employer holds copyright, or where copyright assignment cannot be fulfilled. The copyright assignment form is designed to deal with these situations. However, if you have further queries please contact the editorial office: info@ersj.org.uk

Open access licensing

The European Respiratory Society will publish accepted manuscripts under the terms of one of the following Creative Commons licences, depending upon the option chosen by the author. ERJ Open Research is compliant with the Wellcome Trust's requirements for open access publishing.

Creative Commons Attribution 4.0 International (‘CC-BY’) - under this licence, anyone may share, reuse or adapt the manuscript for any commercial or non-commercial purpose, providing they give credit to the original source and indicate any changes. They may not apply extra restrictions to the content or imply that the original author endorses them or their use.

Creative Commons Attribution-NonCommercial 4.0 International (‘CC-BY-NC’) - under this licence, anyone may share, reuse or adapt the manuscript for any non-commercial purpose, providing they give credit to the original source and indicate any changes. They may not apply extra restrictions to the content or imply that the original author endorses them or their use.

Commercial purposes include

  • copying or downloading articles for further commercial redistribution, sale or licensing;
  • copying, downloading or posting by a site or service that incorporates advertising with such content;
  • the inclusion or incorporation of article content in other works or services that are then available for sale or licensing, for a fee;
  • use of article content by for-profit organisations for promotional purposes;
  • use for the purposes of monetary reward by means of sale, resale, licence, loan, transfer or other form of commercial exploitation such as marketing products.

Author archiving

Authors of ERJ Open Research articles are entitled to deposit the final published version of their manuscripts in an institutional (or other) repository for public archiving provided the terms of the relevant Creative Commons licence are adhered to.

Publication charges

The European Respiratory Society will impose a charge for publishing articles (other than specially commissioned editorials and reviews) in ERJ Open Research. However, initially there will be no charge for manuscripts published under the CC-BY-NC licence. For manuscripts published under the CC-BY licence, there will be a discounted fee.

The current charges are as follows.

CC-BY-NC licence

High-income country

Middle-income country

Low-income country

Spontaneously submitted editorial/letter/correspondence

Free

Free

Free

Originals/reviews

Free

Free

Free

CC-BY licence

High-income country*

Middle-income country

Low-income country

Spontaneously submitted editorial/letter/correspondence

€350

€175

Free

Originals/reviews

€750

€375

Free

The country of origin of a manuscript is determined by the location of the home institution of its corresponding author. Country income bands are as defined by the World Bank at the time of manuscript acceptance (see http://data.worldbank.org/country). 

*European Respiratory Society members in high-income countries will receive a 20% discount.

Please select your Creative Commons licence by downloading, completing and returning the article charge form.

In addition, if you wish to pay article charges by credit card, please download, complete and return the credit card payment form.

Refund policy

If you decide to publish your article with one of our open access licences and pay the article processing charge outlined above, you will be eligible for a refund if:

  1. We publish your article with an incorrect licence, and we fail to correct and republish the article within 1 month of you having informed us of the error; 
  2. We fail to deposit your article to PMC within 2 months of final publication of the article on our own website; or
  3. We fail to publish an author correction or erratum concerning your article within 2 months of you having informed us of the error, subject to our agreement that the reported correction necessitates correction and republication of the article, per our usual policies.

After your paper is accepted: getting the most out of your publication

After your manuscript is accepted, it will be passed to the ERS publications office for copyediting and typesetting before publication. The staff will contact you regarding copyright assignment and publication charges, and will send you a proof of your article along with any queries that have arisen during editing. The ERS aims to publish manuscripts as quickly as possible after acceptance, but cannot do so until it receives your responses.

Once published online, selected papers will promoted by the ERS communications department, through press releases, ERS marketing channels or social media. If your own institution is carrying out press activity around your paper, please let us know. The ERS has also created an authors’ guide to using social media to gain exposure and feedback.

If you have further ideas and would like help promoting your work, please contact the editorial office: info@ersj.org.uk

This page was updated on 30 March, 2017

Categories: 1

0 Replies to “European Respiratory Journal Open Research Papers”

Leave a comment

L'indirizzo email non verrà pubblicato. I campi obbligatori sono contrassegnati *